Immunome, Inc.

IMNM ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2025

Total Assets: $683.2M

Liabilities Breakdown FY2025

Total Liabilities: $48.8M